In Brief: Physio-Control's Lifepak 12
This article was originally published in The Gray Sheet
Physio-Control's Lifepak 12: Firm receives 510(k) clearance for its next-generation defibrillator/monitor series. The device is able to analyze 12-lead ECGs using Marquette Medical Systems' 12SL ECG analysis program, which transmits data from the Lifepak 12 directly to a hospital Muse CV cardiovascular information system. The resuscitation device initially will be available in four basic configurations and in six languages...
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.